Montagu enters exclusive negotiations to sell Arkopharma

Montagu, a leading European private equity firm, announces that it has entered into exclusive negotiations to sell Arkopharma (“the Company”), the European leader in natural consumer health, to Dermapharm AG, a wholly-owned subsidiary of Dermapharm Holding SE (“Dermapharm”), an established and rapidly growing manufacturer of branded pharmaceuticals.

Founded in 1980 and headquartered in Carros, France, Arkopharma is the European leader in natural OTC healthcare products, covering 12 key therapeutic areas under the Arkopharma umbrella brand and its seven strategic sub-brands including Forcapil, Arkorelax, Azinc / Arkovital, Chondro-Aid, Cys-Control, Arkoroyal, and Arkogélules / Arkofluides. During its ownership, Montagu supported Arkopharma’s growth by investing in innovation and accelerating product development. It also invested in operations and in the Company’s international expansion, which helped position the business at the forefront of the natural medicine industry in Europe.

Guillaume Jabalot, Director at Montagu, said: “Arkopharma is a great example of Montagu’s strategy of partnering with high-quality healthcare companies in their pursuit of growth. We are proud of the success Arkopharma has achieved, and we are certain that the Company will continue to thrive under the ownership of Dermapharm. We would especially like to thank the management team and all Arkopharma’s employees for their hard work and dedication, and we wish them all the best on their future journey.”

„Arkopharma is a great example of Montagu’s strategy of partnering with high-quality healthcare companies in their pursuit of growth. We are proud of the success Arkopharma has achieved, and we are certain that the company will continue to thrive under the ownership of Dermapharm“ – Guillaume Jabalot, Director, Montagu

Eric Panijel, CEO of Arkopharma, commented: “I am extremely proud of the whole team that has worked hard to grow and transform Arkopharma, and I am very thankful for Montagu’s support and partnership over the past few years. This is an exciting time for the business as we partner with Dermapharm to enter a new phase of growth and strengthen our leadership in the natural healthcare market.”

„I am extremely proud of the whole team that has worked hard to grow and transform Arkopharma, and I am very thankful for Montagu’s support and partnership over the past few years.“ – Eric Panijel, CEO, Arkopharma

The transaction remains subject to the information and consultation of the French employee representative bodies.

Montagu enters exclusive negotiations to sell Arkopharma